共 66 条
- [31] Choi JW, Zhao YF, Bediako JK, Et al., Estimating environmental fate of tricyclic antidepressants in wastewater treatment plant, Science of the Total Environment, 634, pp. 52-58, (2018)
- [32] Lajeunesse A, Smyth SA, Barclay K, Et al., Distribution of antidepressant residues in wastewater and biosolids following different treatment processes by municipal wastewater treatment plants in Canada, Water Research, 46, 17, pp. 5600-5612, (2012)
- [33] Baker DR, Kasprzyk-Hordern B., Spatial and temporal occurrence of pharmaceuticals and illicit drugs in the aqueous environment and during wastewater treatment
- [34] New developments, Science of the Total Environment, 454, 455, pp. 442-456, (2013)
- [35] He K, Yonetani T, Asada Y, Et al., Simultaneous determination of carbamazepine-N-glucuronide and carbamazepine phase I metabolites in the wastewater by liquid chromatography-tandem mass spectrometry, Microchemical Journal, 145, pp. 1191-1198, (2019)
- [36] Zhang YJ, Geissen SU, Gal C., Carbamazepine and diclofenac
- [37] Removal in wastewater treatment plants and occurrence in water bodies, Chemosphere, 73, 8, pp. 1151-1161, (2008)
- [38] Liang LL, Gao SW, Zhu JC, Et al., The enhanced photocatalytic performance toward carbamazepine by nitrogen-doped carbon dots decorated on BiOBr/CeO2: Mechanism insight and degradation pathways, Chemical Engineering Journal, 391, (2020)
- [39] Liu JL, Wong MH., Pharmaceuticals and personal care products (PPCPs): A review on environmental contamination in China, Environment International, 59, pp. 208-224, (2013)
- [40] Liu JC, Lu GH, Xie ZX, Et al., Occurrence, bioaccumulation and risk assessment of lipophilic pharmaceutically active compounds in the downstream rivers of sewage treatment plants, Science ofthe Total Environment, 511, pp. 54-62, (2015)